Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OTULFI 45 MG SOLUCIÓN INYECTABLE - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OTULFI 45 MG SOLUCIÓN INYECTABLE

Approved

STANDARD

OTULFI 45 MG SOLUCIÓN INYECTABLE

Fresenius Kabi Deutschland Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 16, 2025
Approval ID: d9d5f49e0a4cc9e4
Company: Fresenius Kabi Deutschland Gmbh
Type: Standard

Approval Details

Approval Id: d9d5f49e0a4cc9e4
Drug Cima Aemps Name: OTULFI 45 MG SOLUCIÓN INYECTABLE
Register Number: 1241863004
Holder Company Name: Fresenius Kabi Deutschland Gmbh
Marketing Company Name: Fresenius Kabi España, S.A.U.
Holder Company Detail Path: /organization/3a500adc71d7a432/fresenius-kabi-deutschland-gmbh
Authorization Date: 2025-06-16
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 45 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Fresenius Kabi Deutschland Gmbh
Company Detail Path: /organization/3a500adc71d7a432/fresenius-kabi-deutschland-gmbh

Company Information

Pharmaceutical Company Name: Fresenius Kabi Deutschland Gmbh
Country Name: Sweden
Address: Utländsk Adr - Foreign Addr
Website: http://www.fresenius-kabi.com

Active Ingredients

USTEKINUMAB

45 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 16, 2025

Approval ID

d9d5f49e0a4cc9e4

Type

Standard

Back to CIMA-AEMPS Approvals